Sanjeev Luther's guest appearances

Sanjeev Luther

Empowered Patient Podcast

Outcomes Rocket

Joel Wishkovsky

Suzanne Shugg

Anish Sebastian

Dave Chase

Beth Israel

Sheetal Parmar

Mark Campbell

Omri Shor

Todd Johnson

Rhonda Collins

Heidi Jannenga

Charles Keller

Cory Kidd

Kistein Monkhouse

Deborah Gordon

OwlTail

Cancer is a prevalent condition that impacts not just the patients but also families, employers, and society. Without the right management and medication it can lead to financial loss, reduced quality of life, and even death. In today's episode, we are honored and thrilled to have Sanjeev Luther, CEO and President of Rafael Pharmaceuticals. Sanjeev discusses his company's mission to develop highly effective anti-cancer agents to improve the quality of life of patients with g AML, Burkitts &amp; pancreatic cancer. He shares his insights on innovation, collaborations, AI, challenges in the pharma space, fundamental shifts among regulation due to COVID, and many more. This is a great conversation on oncology in pharma so don't miss it! Click this link to the show notes, transcript, and resources: outcomesrocket.health

Cancer is a prevalent condition that impacts not just the patients but also families, employers, and society. Without the right management and medication it can lead to financial loss, reduced quality of life, and even death. In today's episode, we are honored and thrilled to have Sanjeev Luther, CEO and President of Rafael Pharmaceuticals. Sanjeev discusses his company's mission to develop highly effective anti-cancer agents to improve the quality of life of patients with g AML, Burkitts &amp; pancreatic cancer. He shares his insights on innovation, collaborations, AI, challenges in the pharma space, fundamental shifts among regulation due to COVID, and many more. This is a great conversation on oncology in pharma so don't miss it! Click this link to the show notes, transcript, and resources: <a href="https://outcomesrocket.health/rafael-pharmaceuticals/2021/08/" rel="nofollow" target="_blank">outcomesrocket.health</a>

Discovering Therapy Options for Hard-to-Treat and Rare Cancers with Sanjeev Luther, President & CEO of Rafael Pharmaceuticals

Sanjeev Luther Rafael

Sanjeev Luther, President and CEO, Rafael Pharmaceuticals discusses how tumor cell metabolism has recently attracted substantial attention as an area for the development of drugs to treat cancer.  Rafael is a company leading the field of cancer metabolism with their drug CPI-613 (devimistat) currently being tested in Phase 1, 2, and 3 clinical trials for patients with rare cancers, including pancreatic cancer, acute myeloid leukemia (AML) and Burkitt's lymphoma. @RafaelPharma #RafaelPharma #cancermetabolism #pancreaticcancer #CPI613 RafaelPharma.com Download the transcript here

Sanjeev Luther, President and CEO, Rafael Pharmaceuticals discusses how tumor cell metabolism has recently attracted substantial attention as an area for the development of drugs to treat cancer.  Rafael is a company leading the field of cancer metabolism with their drug CPI-613 (devimistat) currently being tested in Phase 1, 2, and 3 clinical trials for patients with rare cancers, including pancreatic cancer, acute myeloid leukemia (AML) and Burkitt's lymphoma. @RafaelPharma #RafaelPharma #cancermetabolism #pancreaticcancer #CPI613 <a href="http://rafaelpharma.com" rel="noopener nofollow" target="_blank">RafaelPharma.com</a> <a href="http://empoweredpatientradio.com/developing-cancer-metabolism-drugs-with-sanjeev-luther-rafael-pharmaceuticals-transcript" rel="noopener nofollow" target="_blank">Download the transcript here</a>

Developing Cancer Metabolism Drugs with Sanjeev Luther Rafael Pharmaceuticals